Sonoma Pharmaceuticals (SNOA) Liabilities from Discontinued Operations (2016 - 2020)
Sonoma Pharmaceuticals (SNOA) recorded quarterly Liabilities from Discontinued Operations of 646000.0 in Q1 2020, up 476.79% quarter-over-quarter from 112000.0 in Q1 2016.
Sonoma Pharmaceuticals (SNOA) Liabilities from Discontinued Operations (2016 - 2020) Analysis & Trends
Sonoma Pharmaceuticals' Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 646000.0 for Q1 2020.
- In Q1 2020, Liabilities from Discontinued Operations changed N/A year-over-year to 646000.0; the TTM figure through Mar 2020 stood at 646000.0 (changed N/A YoY), while the FY2020 annual figure was 646000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations was 646000.0 for Q1 2020 at Sonoma Pharmaceuticals, up from 112000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 646000.0 in Q1 2020 to a low of 112000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 646,000.00 |
| Mar 31, 2020 | 646,000.00 |
| Mar 31, 2016 | 112,000.00 |
| Mar 31, 2016 | 112,000.00 |